TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 14
1.2 MARKET ATTRACTIVENESS ANALYSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 16
2.5 ASSUMPTIONS & LIMITATIONS 17
3 RESEARCH METHODOLOGY
3.1 DATA MINING 18
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 21
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 INCREASING NOVEL DRUG APPROVALS 26
4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26
4.3 RESTRAINT 27
4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27
4.4 OPPORTUNITY 28
4.4.1 UNTAPPED MARKETS 28
4.5 IMPACT OF CORONAVIRUS (COVID)-19 28
4.5.1 OVERVIEW 28
4.5.2 IMPACT ON PLAYERS 28
4.5.3 IMPACT ON CLINICAL TRIALS 28
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 29
5.1.1 R&D AND DESIGNING 29
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION 30
5.1.4 MARKETING & SALES 30
5.1.5 POST-SALES MONITORING 30
5.2 PORTER’S FIVE FORCES MODEL 30
5.2.1 BARGAINING POWER OF SUPPLIERS 31
5.2.2 BARGAINING POWER OF BUYERS 31
5.2.3 THREAT OF NEW ENTRANTS 32
5.2.4 THREAT OF SUBSTITUTES 32
5.2.5 RIVALRY 32
5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32
5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32
5.3.2 ADVENT OF PATCH CLAMP ASSAY 33
5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33
5.4 CUSTOMER NEED ANALYSIS 33
5.4.1 OVERVIEW 33
5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33
5.4.3 CAUSE AND EFFECT ANALYSIS 34
6 GLOBAL HERG SCREENING MARKET, BY TYPE
6.1 OVERVIEW 35
6.2 GENE KCNH2 36
6.3 MUTANT KCNH2 36
7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL
7.1 OVERVIEW 37
7.2 VOLTAGE-GATED ION CHANNEL 39
7.3 LIGAND-GATED ION CHANNEL 39
7.4 OTHERS 40
8 GLOBAL HERG SCREENING MARKET, BY APPLICATION
8.1 OVERVIEW 41
8.2 ANTIARRHYTHMIC 43
8.3 ANTIPSYCHOTIC 43
8.4 ANTIBIOTIC 43
8.5 OTHERS 44
9 GLOBAL HERG SCREENING MARKET, BY REGION
9.1 OVERVIEW 45
9.2 AMERICAS 47
9.2.1 NORTH AMERICA 49
9.2.1.1 US 51
9.2.1.2 CANADA 52
9.2.2 LATIN AMERICA 53
9.3 EUROPE 54
9.3.1 WESTERN EUROPE 56
9.3.1.1 GERMANY 58
9.3.1.2 FRANCE 59
9.3.1.3 UK 60
9.3.1.4 ITALY 61
9.3.1.5 SPAIN 62
9.3.1.6 REST OF WESTERN EUROPE 63
9.3.2 EASTERN EUROPE 64
9.4 ASIA-PACIFIC 65
9.4.1 CHINA 67
9.4.2 JAPAN 68
9.4.3 INDIA 69
9.4.4 AUSTRALIA 70
9.4.5 SOUTH KOREA 71
9.4.6 REST OF ASIA-PACIFIC 72
9.5 MIDDLE EAST & AFRICA 73
9.5.1 MIDDLE EAST 75
9.5.2 AFRICA 76
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 77
10.2 MARKET RANKING ANALYSIS 77
10.3 COMPETITIVE BENCHMARKING 78
10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79
10.4.1 PARTNERSHIP 79
10.4.2 ACQUISITIONS 80
10.4.3 COLLABORATION 80
10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81
10.5.1 SALES & OPERATING PROFIT MARGIN 81
10.5.2 R&D EXPENDITURE 81
11 COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC. 82
11.1.1 COMPANY OVERVIEW 82
11.1.2 FINANCIAL OVERVIEW 82
11.1.3 PRODUCTS/SERVICES OFFERED 83
11.1.4 KEY DEVELOPMENTS 83
11.1.5 SWOT ANALYSIS 83
11.1.6 KEY STRATEGIES 83
11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84
11.2.1 COMPANY OVERVIEW 84
11.2.2 FINANCIAL OVERVIEW 84
11.2.3 PRODUCTS/SERVICES OFFERED 85
11.2.4 KEY DEVELOPMENTS 85
11.2.5 SWOT ANALYSIS 86
11.2.6 KEY STRATEGIES 86
11.3 MERCK KGAA 87
11.3.1 COMPANY OVERVIEW 87
11.3.2 FINANCIAL OVERVIEW 87
11.3.3 PRODUCTS/SERVICES OFFERED 88
11.3.4 KEY DEVELOPMENTS 88
11.3.5 SWOT ANALYSIS 88
11.3.6 KEY STRATEGIES 88
11.4 EUROFINS DISCOVERX CORPORATION 89
11.4.1 COMPANY OVERVIEW 89
11.4.2 FINANCIAL OVERVIEW 89
11.4.3 PRODUCTS/SERVICES OFFERED 90
11.4.4 KEY DEVELOPMENTS 90
11.4.5 SWOT ANALYSIS 90
11.4.6 KEY STRATEGIES 91
11.5 ABCAM PLC. 92
11.5.1 COMPANY OVERVIEW 92
11.5.2 FINANCIAL OVERVIEW 92
11.5.3 PRODUCTS/SERVICES OFFERED 93
11.5.4 KEY DEVELOPMENTS 93
11.5.5 SWOT ANALYSIS 94
11.5.6 KEY STRATEGIES 94
11.6 CYPROTEX LIMITED 95
11.6.1 COMPANY OVERVIEW 95
11.6.2 FINANCIAL OVERVIEW 95
11.6.3 PRODUCTS/SERVICES OFFERED 95
11.6.4 KEY DEVELOPMENTS 95
11.6.5 SWOT ANALYSIS 96
11.6.6 KEY STRATEGIES 96
11.7 B‘SYS GMBH 97
11.7.1 COMPANY OVERVIEW 97
11.7.2 FINANCIAL OVERVIEW 97
11.7.3 PRODUCTS/SERVICES OFFERED 97
11.7.4 KEY DEVELOPMENTS 97
11.7.5 SWOT ANALYSIS 98
11.7.6 KEY STRATEGIES 98
11.8 CREATIVE BIOARRAY 99
11.8.1 COMPANY OVERVIEW 99
11.8.2 FINANCIAL OVERVIEW 99
11.8.3 PRODUCTS/SERVICES OFFERED 99
11.8.4 KEY DEVELOPMENTS 99
11.8.5 SWOT ANALYSIS 100
11.8.6 KEY STRATEGIES 100
11.9 METRION BIOSCIENCES LTD 101
11.9.1 COMPANY OVERVIEW 101
11.9.2 FINANCIAL OVERVIEW 101
11.9.3 PRODUCTS/SERVICES OFFERED 101
11.9.4 KEY DEVELOPMENTS 101
11.9.5 SWOT ANALYSIS 102
11.9.6 KEY STRATEGIES 102
11.10 AURORA BIOMED INC. 103
11.10.1 COMPANY OVERVIEW 103
11.10.2 FINANCIAL OVERVIEW 103
11.10.3 PRODUCTS/SERVICES OFFERED 103
11.10.4 KEY DEVELOPMENTS 103
11.10.5 SWOT ANALYSIS 104
11.10.6 KEY STRATEGIES 104
12 APPENDIX
12.1 REFERENCES 105
12.2 RELATED REPORTS 105
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
TABLE 3 GLOBAL HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 36
TABLE 4 GLOBAL HERG SCREENING MARKET, FOR GENE KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
TABLE 5 GLOBAL HERG SCREENING MARKET, FOR MUTANT KCNH2, BY REGION, 2022-2030 (USD MILLION) 36
TABLE 6 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 38
TABLE 7 GLOBAL HERG SCREENING MARKET, FOR VOLTAGE-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
TABLE 8 GLOBAL HERG SCREENING MARKET, FOR LIGAND-GATED ION CHANNEL, BY REGION, 2022-2030 (USD MILLION) 39
TABLE 9 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 40
TABLE 10 GLOBAL HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 42
TABLE 11 GLOBAL HERG SCREENING MARKET, FOR ANTIARRHYTHMIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 12 GLOBAL HERG SCREENING MARKET, FOR ANTIPSYCHOTIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 13 GLOBAL HERG SCREENING MARKET, FOR ANTIBIOTIC, BY REGION, 2022-2030 (USD MILLION) 43
TABLE 14 GLOBAL HERG SCREENING MARKET, FOR OTHERS, BY REGION, 2022-2030 (USD MILLION) 44
TABLE 15 GLOBAL HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 46
TABLE 16 AMERICAS: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 47
TABLE 17 AMERICAS: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 47
TABLE 18 AMERICAS: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 48
TABLE 19 AMERICAS: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 48
TABLE 20 NORTH AMERICA: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 49
TABLE 21 NORTH AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 49
TABLE 22 NORTH AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 50
TABLE 23 NORTH AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 50
TABLE 24 US: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 51
TABLE 25 US: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 51
TABLE 26 US: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 51
TABLE 27 CANADA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 52
TABLE 28 CANADA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 52
TABLE 29 CANADA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 52
TABLE 30 LATIN AMERICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 53
TABLE 31 LATIN AMERICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 53
TABLE 32 LATIN AMERICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 53
TABLE 33 EUROPE: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 54
TABLE 34 EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 54
TABLE 35 EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 55
TABLE 36 EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 55
TABLE 37 WESTERN EUROPE: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 56
TABLE 38 WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
TABLE 39 WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 57
TABLE 40 WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 57
TABLE 41 GERMANY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
TABLE 42 GERMANY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 58
TABLE 43 GERMANY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 58
TABLE 44 FRANCE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
TABLE 45 FRANCE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 59
TABLE 46 FRANCE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 59
TABLE 47 UK: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
TABLE 48 UK: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 60
TABLE 49 UK: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 60
TABLE 50 ITALY: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 61
TABLE 51 ITALY: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 61
TABLE 52 ITALY: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 61
TABLE 53 SPAIN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
TABLE 54 SPAIN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 62
TABLE 55 SPAIN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 62
TABLE 56 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
TABLE 57 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 63
TABLE 58 REST OF WESTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 63
TABLE 59 EASTERN EUROPE: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
TABLE 60 EASTERN EUROPE: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 64
TABLE 61 EASTERN EUROPE: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 64
TABLE 62 ASIA-PACIFIC: HERG SCREENING MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 65
TABLE 63 ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 65
TABLE 64 ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 66
TABLE 65 ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 66
TABLE 66 CHINA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
TABLE 67 CHINA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 67
TABLE 68 CHINA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 67
TABLE 69 JAPAN: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 68
TABLE 70 JAPAN: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 68
TABLE 71 JAPAN: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 68
TABLE 72 INDIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
TABLE 73 INDIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 69
TABLE 74 INDIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 69
TABLE 75 AUSTRALIA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 70
TABLE 76 AUSTRALIA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 70
TABLE 77 AUSTRALIA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 70
TABLE 78 SOUTH KOREA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 71
TABLE 79 SOUTH KOREA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 71
TABLE 80 SOUTH KOREA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 71
TABLE 81 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
TABLE 82 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 72
TABLE 83 REST OF ASIA-PACIFIC: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 72
TABLE 84 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY REGION, 2022–2030 (USD MILLION) 73
TABLE 85 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 73
TABLE 86 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 74
TABLE 87 MIDDLE EAST & AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 74
TABLE 88 MIDDLE EAST: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 75
TABLE 89 MIDDLE EAST: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 75
TABLE 90 MIDDLE EAST: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 75
TABLE 91 AFRICA: HERG SCREENING MARKET, BY TYPE, 2022-2030 (USD MILLION) 76
TABLE 92 AFRICA: HERG SCREENING MARKET, BY ION CHANNEL, 2022-2030 (USD MILLION) 76
TABLE 93 AFRICA: HERG SCREENING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 76
TABLE 94 TOP PLAYERS IN THE GLOBAL HERG SCREENING MARKET 77
TABLE 95 PARTNERSHIP: GLOBAL HERG SCREENING MARKET 79
TABLE 96 ACQUISITIONS: GLOBAL HERG SCREENING MARKET 80
TABLE 97 COLLABORATION: GLOBAL HERG SCREENING MARKET 80
TABLE 98 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 83
TABLE 99 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS/SERVICES OFFERED 85
TABLE 100 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY DEVELOPMENTS 85
TABLE 101 MERCK KGAA: PRODUCTS/SERVICES OFFERED 88
TABLE 102 EUROFINS DISCOVERX CORPORATION: PRODUCTS/SERVICES OFFERED 90
TABLE 103 EUROFINS DISCOVERX CORPORATION: KEY DEVELOPMENTS 90
TABLE 104 ABCAM PLC.: PRODUCTS/SERVICES OFFERED 93
TABLE 105 ABCAM PLC.: KEY DEVELOPMENTS 93
TABLE 106 CYPROTEX LIMITED: PRODUCTS/SERVICES OFFERED 95
TABLE 107 B‘SYS GMBH: PRODUCTS/SERVICES OFFERED 97
TABLE 108 CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED 99
TABLE 109 METRION BIOSCIENCES LTD: PRODUCTS/SERVICES OFFERED 101
TABLE 110 AURORA BIOMED INC.: PRODUCTS/SERVICES OFFERED 103
| ※参考情報 HERGスクリーニングは、薬剤が心臓の細胞におけるHERGチャネル(ヒトエルゴトキシン関連遺伝子)に与える影響を分析する手法です。HERGチャネルは、心筋の活動電位の調整に関与する重要なイオンチャネルであり、これに対する阻害作用は、心電図のQT間隔の延長や致死的な不整脈のリスクをもたらす可能性があります。したがって、新薬の開発において、HERGチャネルに対する親和性を評価することは非常に重要なステップとなります。 HERGスクリーニングの種類には、主に二つのアプローチがあります。一つは、細胞ベースのアッセイです。細胞ベースのアッセイでは、HERGチャネルを発現させた細胞株を用いて、薬剤がチャネルに与える影響をリアルタイムで観察することができます。通常、電流計測技術や蛍光技術を用いてチャネルの活性を評価します。例えば、電流計測では、薬剤添加前後の電流変化をモニタリングし、HERGチャネルがどの程度阻害されたかを定量化します。 もう一つのアプローチは、コンピューターベースのシミュレーションです。これは、薬剤の分子構造に基づいて、HERGチャネルと薬剤の相互作用をモデル化する手法です。この方法により、大量の化合物に対して迅速にスクリーニングを行うことが可能となり、初期段階でのリード化合物の選定を効率化できます。最近では、機械学習やAIを活用することで、更に予測精度が向上しています。 HERGスクリーニングの用途は、新薬候補の早期選定や毒性評価、化合物の最適化に広がります。特に、心臓に関連する病気や状態を対象とした薬剤開発では、HERGチャネルに対する安全性評価が必須となります。例えば、心不全や不整脈の治療に関連する薬剤の開発において、既存の薬剤のHERG阻害作用を評価することで、より安全性の高い治療薬を開発することが目指されています。また、HERGスクリーニングは、非心臓用薬剤でも重要な位置を占めており、特にがん治療薬や抗ウイルス薬などでも注目されています。 関連技術としては、電気生理学的手法やマイクロ流体デバイスがあります。電気生理学的手法は、細胞膜の脱分極により生じる電流を計測するため、HERGチャネルの動作を詳細に解析することができます。一方、マイクロ流体デバイスは、少量の試料でスクリーニングが可能で、短時間での評価を実現します。これらの技術により、スクリーニングプロセスは効率化され、より多様な化合物の評価が行えるようになっています。 最近の研究では、HERGスクリーニングの結果をもとにしたリード化合物の改変や構造活性相関(SAR)研究が進められています。このようなアプローチにより、HERGチャネルに対する阻害を避けつつ、薬効を高めるための分子設計が行われています。新しい化合物の設計プロセスでは、効率的に安全性を評価するために、HERGスクリーニングの重要性が増しています。 加えて、HERGチャネルの動作に関連する分子メカニズムについての理解が進む中で、新たなターゲットが提案されています。これにより、HERG以外のチャネルや受容体の影響も評価することが重視されるようになり、より包括的な安全性評価が期待されています。今後の研究においては、HERGスクリーニングの重要性はさらに高まると考えられます。 このように、HERGスクリーニングは薬剤開発において欠かせないプロセスであり、心血管系の安全性評価を中心に様々な分野で活用されています。特に、初期スクリーニングでのHERG親和性の評価は、後の開発段階での安全性向上に貢献するため、今後もますます重要な役割を果たすことが期待されます。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

